Acasti Pharma Inc. (ACST)

USD 3.37

(4.01%)

Annual Balance Sheets

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 73.3 Million 79.12 Million 128.62 Million 62.45 Million 22.85 Million 36.3 Million
Total Current Assets 24.01 Million 29.29 Million 45.53 Million 62.37 Million 16.07 Million 27.95 Million
Cash And Short Term Investments 23 Million 27.89 Million 43.66 Million 60.73 Million 14.24 Million 25.75 Million
Cash and Cash Equivalents 23 Million 27.87 Million 30.33 Million 50.94 Million 14.24 Million 16.86 Million
Short Term Investments - 15 Thousand 13.32 Million 9.78 Million - 8.88 Million
Net Receivables 722 Thousand 802 Thousand 548 Thousand 530 Thousand 546 Thousand 1.18 Million
Inventory - - - - 1.09 Million 969.14 Thousand
Other Current Assets 283 Thousand 598 Thousand 1.32 Million 1.11 Million 195 Thousand 48.68 Thousand
Total Non-Current Assets 49.28 Million 49.83 Million 83.08 Million 86 Thousand 6.77 Million 8.34 Million
Net PPE 24 Thousand 567 Thousand 315 Thousand 86 Thousand 2.05 Million 2.1 Million
Good Will And Intangible Assets 49.26 Million 49.26 Million 82.77 Million - 4.24 Million 5.79 Million
Good Will 8.13 Million 8.13 Million 12.96 Million - - -
Intangible Assets 41.12 Million 41.12 Million 69.81 Million - 4.24 Million 5.79 Million
Long-Term Investments - - - - - 20.22 Thousand
Tax Assets - - - - - 2.00
Other Non Current Assets -1.00 - - - 473 Thousand 417.16 Thousand
Other Assets 1.00 - - - -0.00 0.00
Total Liabilities 11.55 Million 11.16 Million 20.35 Million 6.79 Million 9.85 Million 25.84 Million
Total Current Liabilities 1.68 Million 3.41 Million 3.26 Million 1.57 Million 7.39 Million 13.66 Million
Account Payables 1 Million 1.24 Million 1.67 Million 115 Thousand 1.71 Million 3.04 Million
Tax Payables - - - - - -
Short Term Debt - 75 Thousand 104 Thousand 86 Thousand 76 Thousand 1.36 Million
Deferred Revenue - -1.24 Million - - - 2.00
Other Current Liabilities 677 Thousand 3.33 Million 1.47 Million 1.37 Million 5.6 Million 9.26 Million
Total Non Current Liabilities 9.87 Million 7.75 Million 17.09 Million 5.21 Million 2.46 Million 12.18 Million
Long-Term Debt - 410 Thousand 191 Thousand - 71 Thousand -
Deferred Revenue Non Current - -9929.62 - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 4.35 Million 9929.62 10 Thousand 5.21 Million 2.39 Million 12.18 Million
Other Liabilities - - - 0.00 - 1.00
Total Equity 61.74 Million 67.95 Million 108.27 Million 55.66 Million 12.99 Million 10.45 Million
Stock Holders Equity 61.74 Million 67.95 Million 108.27 Million 55.66 Million 12.99 Million 10.45 Million
Common Stock 261.03 Million 258.29 Million 257.99 Million 197.19 Million 137.42 Million 96.85 Million
Retained Earnings -211.11 Million -198.26 Million -155.83 Million -146.01 Million -126.34 Million -92.82 Million
Accumulated other comprehensive income -6.03 Million -6.03 Million -6.03 Million -6.33 Million -7.88 Million -888.25 Thousand
Common Stock Equity 61.74 Million 67.95 Million 108.27 Million 55.66 Million 12.99 Million 10.45 Million
Capital Lease Obligation - 485 Thousand 295 Thousand 86 Thousand 147 Thousand 70.99 Thousand
Total Investments - 15 Thousand 13.32 Million 9.78 Million - 8.9 Million
Total Debt - 485 Thousand 295 Thousand 86 Thousand 147 Thousand 1.36 Million
Net Debt -23 Million -27.39 Million -30.04 Million -50.85 Million -14.09 Million -15.5 Million

Balance Sheet Charts